ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 609,51
1,14%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Erytech Pharma SA (ERYP)

  7. Erytech Pharma SA (ERYP) Actualités

ERYP

Erytech Pharma (ERYP)

Erytech Pharma SA
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ERYP
DateHeureSourceTitreSymboleSociété
30/06/202317h33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
29/06/202321h53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ERYPErytech Pharma SA
29/06/202321h52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ERYPErytech Pharma SA
28/06/202314h54Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
24/05/202322h52Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ERYPErytech Pharma SA
09/05/202316h30AllPennyStocks.comMicro Cap Bid Up Right Before Opening BellNASDAQ:ERYPErytech Pharma SA
14/02/202318h51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
25/08/202219h21Dow Jones NewsErytech Pharma Shares Hit 52-Week Low After Ending Plans for License Application for GraspaNASDAQ:ERYPErytech Pharma SA
27/04/202218h51Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ERYPErytech Pharma SA
15/02/202212h30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ERYPErytech Pharma SA
21/09/202118h51Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ERYPErytech Pharma SA
07/05/202122h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ERYPErytech Pharma SA
05/05/202122h51Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ERYPErytech Pharma SA
29/01/202122h37Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ERYPErytech Pharma SA
13/10/202012h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ERYPErytech Pharma SA
08/10/202023h24Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:ERYPErytech Pharma SA
22/09/202012h01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ERYPErytech Pharma SA
14/09/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2020NASDAQ:ERYPErytech Pharma SA
06/08/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2020NASDAQ:ERYPErytech Pharma SA
10/07/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020NASDAQ:ERYPErytech Pharma SA
09/06/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 30, 2020NASDAQ:ERYPErytech Pharma SA
07/05/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2020NASDAQ:ERYPErytech Pharma SA
06/04/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2020NASDAQ:ERYPErytech Pharma SA
06/03/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – February 29, 2020NASDAQ:ERYPErytech Pharma SA
04/02/202018h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2020NASDAQ:ERYPErytech Pharma SA
10/01/202017h45GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2019NASDAQ:ERYPErytech Pharma SA
02/12/201918h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2019NASDAQ:ERYPErytech Pharma SA
05/11/201923h00GlobeNewswire Inc.ERYTECH to Host Third Quarter 2019 Conference Call and Business Update on November 8, 2019NASDAQ:ERYPErytech Pharma SA
05/11/201918h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2019NASDAQ:ERYPErytech Pharma SA
04/10/201918h00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2019NASDAQ:ERYPErytech Pharma SA
 Showing the most relevant articles for your search:NASDAQ:ERYP

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
EU
MC
Lvmh Moet Hennessy Louis...
EU
ML
Michelin
EU
RNO
Renault
EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
EU
BNP
BNP Paribas
EU
EN
Bouygues
NYSE
MRK
Merck
FTSE
UKX
FTSE 100
EU
PX4
SBF 120
EU
PX1
CAC 40
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés